Results 31 to 40 of about 1,634 (199)
Taiwanese Journal of Obstetrics & Gynecology, 2023 Objective: To evaluate the safety and efficacy of atosiban and ritodrine in pregnant women who were hospitalized for threatened preterm labor (TPL). Materials and methods: Diagnosis records of preterm labor and subsequent pregnancy-related records and ...
Guk Won Kim +5 more
doaj +1 more source
BMC Complementary and Alternative Medicine, 2019 Background The herbal medicine Bryophyllum pinnatum has been used as a tocolytic agent in anthroposophic medicine and, recently, in conventional settings alone or as an add-on medication with tocolytic agents such as atosiban or nifedipine.
S. Santos +5 more
doaj +1 more source
СРАВНЕНИЕ ТОКОЛИЗА ГЕКСОПРЕНАЛИНОМ И АТОЗИБАНОМ
Медицинский совет, 2017 The aim of the study was to compare the efficacy and safety of tocolytic agents - atosiban and hexoprenaline.Patients and methods: The study included 119 pregnant women with threatening preterm labour between 28 to 34 weeks of gestation.
О. Р. Баев +4 more
doaj +1 more source
Artery Research, 2009 Objective: Atosiban and ritodrine are frequently used tocolytics. Only a few studies investigated the hemodynamic effects of atosiban. We therefore aimed to study the central and peripheral hemodynamics of both medications.
I.G.M. Fabry, P. De Paepe, L. Van Bortel
doaj +1 more source
P4.02 EFFECTS OF TOCOLYTICAL MEDICATION ON BLOOD PRESSURE AND BLOOD PRESSURE AMPLIFICATION
Artery Research, 2009 Objective: Atosiban (oxytocin-antagonist) and ritodrine (β-agonist) are frequently used tocolytics. Only a few studies investigated the hemodynamic effects of atosiban.
I.G.M. Fabry, P. De Paepe, L. Van Bortel
doaj +1 more source
Atosiban in the Management of Preterm Labour [PDF]
Clinical Medicine Insights: Women's Health, 2011 The purpose of this review was to look at the evidence available for the use of atosiban as a tocolytic in cases of threatened preterm labour. A Royal College of Obstetricians and Gynaecologists Green Top Guideline concluded that there was no clear evidence to show a benefit to tocolysis in reducing perinatal and neonatal morbidity and mortality ...
Fullerton, Gail M +3 more
openaire +2 more sources
Hexoprenaline Compared with Atosiban as Tocolytic Treatment for Preterm Labor
Geburtshilfe und Frauenheilkunde, 2022 Introduction Preterm birth is defined as a live birth before 37 weeks of gestation and is associated with increased neonatal morbidity and mortality. The aim of this study is to compare the efficacy of hexoprenaline and atosiban for short- and long-term ...
Ebba Kirchhoff +10 more
semanticscholar +1 more source
Atosiban versus betamimetics in the treatment of preterm labour in Germany: an economic evaluation
BMC Pregnancy and Childbirth, 2009 Background The use of tocolytics is central in delaying birth; however, therapeutic options vary in effectiveness and adverse events profiles, which in turn could have consequences for medical resource use and cost of treatment. Betamimetics are commonly
Connolly Mark, Wex Jaro, Rath Werner
doaj +1 more source
BMJ Open, 2022 Under the heading Sample size. Old text: Based on the APOSTEL three data, the proportion of adverse perinatal outcome in women randomised between 30 and 34 weeks’ gestation and treated with atosiban was 6%.
semanticscholar +1 more source
Frontiers in Pharmacology, 2021 Methamphetamine (METH) is a highly neurotoxic psychoactive substance that can directly damage the central nervous system through prolonged use. Oxytocin (OT) has attracted much attention because of its neuroprotective effect.
Chunli Li +6 more
doaj +1 more source